Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger L Albin

Showing results (31-40 of 242) with videos related to

Pageof 25
Sort By:
Neurologic Clinics|November 30, 2014
Huntington disease: pathogenesis and treatmentPraveen Dayalu, Roger L Albin
Movement Disorders : Official Journal of the Movement Disorder Society|March 22, 2021
Reply to: "Cell Therapy for Huntington's Disease: Learning from Failure"Roger L Albin, Jeffrey H Kordower
Neurology|September 10, 2008
Dopamine and epilepsy: hints of complex subcortical rolesSheryl R Haut, Roger L Albin
Progress in Brain Research|March 6, 2022
The way forward for cognition in Parkinson's diseaseNandakumar S Narayanan, Roger L Albin
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2021
Interviewing Mice and the Functions of Striatal DopamineDaniel K Leventhal, Roger L Albin
Neurology|February 13, 2003
Initial agonist treatment of Parkinson disease: a critiqueRoger L Albin, Kirk A Frey
The Lancet. Neurology|November 4, 2019
Increased striatal dopamine in carriers of GBA mutations: compensation or epiphenomenon?Nicolaas I Bohnen, Roger L Albin
Movement Disorders : Official Journal of the Movement Disorder Society|August 12, 2020
A Failed FutureRoger L Albin, Jeffrey H Kordower
The Lancet. Neurology|February 20, 2018
Hypercholinergic activity in LRRK2 Parkinson's diseaseNicolaas I Bohnen, Roger L Albin
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 7, 2016
Reverse Translation in Parkinson DiseaseRoger L Albin, Kirk A Frey
Pageof 25

Showing results (31-40 of 242) with videos related to

Sort By:
Pageof 25
Neurologic Clinics|November 30, 2014
Huntington disease: pathogenesis and treatmentPraveen Dayalu, Roger L Albin
Movement Disorders : Official Journal of the Movement Disorder Society|March 22, 2021
Reply to: "Cell Therapy for Huntington's Disease: Learning from Failure"Roger L Albin, Jeffrey H Kordower
Neurology|September 10, 2008
Dopamine and epilepsy: hints of complex subcortical rolesSheryl R Haut, Roger L Albin
Progress in Brain Research|March 6, 2022
The way forward for cognition in Parkinson's diseaseNandakumar S Narayanan, Roger L Albin
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2021
Interviewing Mice and the Functions of Striatal DopamineDaniel K Leventhal, Roger L Albin
Neurology|February 13, 2003
Initial agonist treatment of Parkinson disease: a critiqueRoger L Albin, Kirk A Frey
The Lancet. Neurology|November 4, 2019
Increased striatal dopamine in carriers of GBA mutations: compensation or epiphenomenon?Nicolaas I Bohnen, Roger L Albin
Movement Disorders : Official Journal of the Movement Disorder Society|August 12, 2020
A Failed FutureRoger L Albin, Jeffrey H Kordower
The Lancet. Neurology|February 20, 2018
Hypercholinergic activity in LRRK2 Parkinson's diseaseNicolaas I Bohnen, Roger L Albin
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 7, 2016
Reverse Translation in Parkinson DiseaseRoger L Albin, Kirk A Frey
Pageof 25